Brand name: Retin-A
Retin-A is a medicine containing the active ingredient(s) tretinoin. On this page you will find out more about Retin-A, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: tretinoin
No information has been found for the selected product. Contact your pharmacist, healthcare professional, or phone healthdirect on 1800 022 222 if you require further help.
Need more information?
These trusted information partners have more on this topic.
Found 373 results
Retinitis pigmentosa
The retina is located at the back of the eye. This thin layer of light-sensitive cells sends information on shape, colour, pattern and movement to the brain via the optic nerve. There are special light sensing cells in the retina, called rods and cones (see explanation below).
Read more on Better Health Channel website
Retinal Detachment | myVMC
Retinal detachment refers to an eye condition in which the eye’s retina becomes detached from the vitreous fluid and layers of tissue that surround and support it.
Read more on myVMC – Virtual Medical Centre website
Retinal detachment - detached retina
Retinal detachment (detached retina) is a medical emergency when the retina becomes separated from the inside of the eye. Warning signs include a sudden increase in floaters or flashes. Seek immediate medical attention. This could save your sight.
Read more on myDr website
Retinal detachment - Better Health Channel
If a detached retina is not treated, it can lead to total blindness.
Read more on Better Health Channel website
Retinal detachment surgery - Better Health Channel
Read more on Better Health Channel website
Retinoschisis | myVMC
Retinoschisis occurs when the eye's retina splits into two layers. It causes gradual visual loss and may lead to retinal detachment.
Read more on myVMC – Virtual Medical Centre website
Diabetic Macular Oedema | myVMC
Diabetic macular oedema is a sight-threatening eye condition
Read more on myVMC – Virtual Medical Centre website
Floaters: tiny particles in the eye - myDr.com.au
Floaters are tiny clumps of debris suspended in the eyeball. They cause visual disturbances, such as specks or tiny threads that float across your vision.
Read more on myDr website
What is an eye test? | Vision Initiative
Information on the tests included in an eye test
Read more on Vision Initiative website
Eye Health | Common Eye Conditions | Glossary of Eye Conditions
A glossary of eye conditions including information on cataract, diabetic retinopathy, as well as definitions of myopia, hyperopia, and glaucoma. Read more.
Read more on Fred Hollows Foundation website
Found 190 results
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment | Cochrane
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment
Read more on Cochrane (Australasian Centre) website
Interventions for prevention of giant retinal tear in the fellow eye | Cochrane
A giant retinal tear is a full-thickness retinal break that extends for 90 degrees or more around the circumference of the retina, in the presence of posterior vitreous detachment (when the vitreous comes away from the retina). Giant retinal tears cause visual loss as a result of the associated retinal detachment. They can be difficult to treat due to the large area of retinal involvement and the high risk of re-detachment following vitreoretinal surgery, often related to the development of proliferative vitreoretinopathy (a scarring process that can happen on the inner or outer surface of the retina and in the vitreous cavity after retinal detachment). As the fellow eye has an increased risk of developing giant retinal tear and retinal detachment, prophylactic 360-degree treatments with laser photocoagulation, cryotherapy or encircling scleral buckling have been proposed to reduce this risk. This review did not find any strong evidence in the form of prospective randomised controlled trials or case-control studies to support or refute these prophylactic treatments.
Read more on Cochrane (Australasian Centre) website
Surgical interventions for rhegmatogenous retinal detachment | Cochrane
In this review we aimed to determine whether pneumatic retinopexy or scleral buckle is a better surgical treatment for rhegmatogenous retinal detachment (RRD).
Read more on Cochrane (Australasian Centre) website
Use of vitamin A and fish oils for retinitis pigmentosa | Cochrane
We investigated how well vitamin A and fish oils work in delaying the progression of visual loss in people with retinitis pigmentosa (RP), and whether these treatments are safe.
Read more on Cochrane (Australasian Centre) website
Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy after retinal reattachment surgery | Cochrane
Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy after retinal reattachment surgery
Read more on Cochrane (Australasian Centre) website
Steroids inserted into the eye versus observation for macular edema secondary to central retinal vein occlusion | Cochrane
Steroids inserted into the eye versus observation for macular edema secondary to central retinal vein occlusion
Read more on Cochrane (Australasian Centre) website
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion | Cochrane
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
Read more on Cochrane (Australasian Centre) website
Treatments for acute central retinal artery occlusion (blockage of the blood supply to the retina of the eye) | Cochrane
Treatments for acute central retinal artery occlusion (blockage of the blood supply to the retina of the eye)
Read more on Cochrane (Australasian Centre) website
Optical coherence tomography measurement of central retinal thickness to diagnose diabetic macular oedema | Cochrane
Optical coherence tomography measurement of central retinal thickness to diagnose diabetic macular oedema
Read more on Cochrane (Australasian Centre) website
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion | Cochrane
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
Read more on Cochrane (Australasian Centre) website
